ArriVent BioPharma (AVBP) Prepaid Assets (2023 - 2026)
ArriVent BioPharma (AVBP) posted Prepaid Assets of $20.8 million for Q1 2026, up 34613.33% sequentially from $60000.0 in Q4 2025, and up 2159.0% YoY from $922000.0 in Q1 2025.
ArriVent BioPharma (AVBP) Prepaid Assets (2023 - 2026) Analysis & Trends
ArriVent BioPharma has reported Prepaid Assets for 4 years, with the latest figure at $20.8 million in Q1 2026.
- Quarterly Prepaid Assets rose 2159.0% year-over-year to $20.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.8 million (up 2159.0% YoY) and the FY2025 annual result came in at $60000.0, down 99.26% from the prior year.
- Prepaid Assets climbed to $20.8 million in Q1 2026 per AVBP's latest filing, from $60000.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $20.8 million in Q1 2026 and troughed at $60000.0 in Q4 2025.
- A 4-year average of $6.9 million and a median of $7.8 million in 2024 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2024 and 2025: Prepaid Assets surged 6240.62% in 2024, then sank 99.26% in 2025.
- Over 4 years, Prepaid Assets stood at $128000.0 in 2023, then soared by 6240.62% to $8.1 million in 2024, then tumbled by 99.26% to $60000.0 in 2025, then jumped by 34613.33% to $20.8 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $20.8 million, $60000.0, and $450000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | ArriVent BioPharma | 1.43 Bn | 1.43 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.05 Mn |
| Mar 31, 2026 | 20.83 Mn |
| Dec 31, 2025 | 60,000.00 |
| Sep 30, 2025 | 450,000.00 |
| Jun 30, 2025 | 13.17 Mn |
| Mar 31, 2025 | 922,000.00 |
| Dec 31, 2024 | 8.12 Mn |
| Sep 30, 2024 | 7.90 Mn |
| Jun 30, 2024 | 9.84 Mn |
| Mar 31, 2024 | 7.76 Mn |
| Dec 31, 2023 | 128,000.00 |